AngioSoma Company Top Management

GSTC Stock  USD 0.0001  0.00  0.00%   
AngioSoma employs about 6 people. The company is managed by 6 executives with a total tenure of roughly 14 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Evaluation of AngioSoma's management performance can provide insight into the firm performance.
Robert CPA  Insider
Treasurer CFO
Brooke Greenwald  Insider
Chief Officer
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in AngioSoma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

AngioSoma Management Team Effectiveness

The company has return on total asset (ROA) of (44.2826) % which means that it has lost $44.2826 on every $100 spent on assets. This is way below average. AngioSoma's management efficiency ratios could be used to measure how well AngioSoma manages its routine affairs as well as how well it operates its assets and liabilities.

AngioSoma Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. AngioSoma Price Series Summation is a cross summation of AngioSoma price series and its benchmark/peer.

AngioSoma Notable Stakeholders

An AngioSoma stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as AngioSoma often face trade-offs trying to please all of them. AngioSoma's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting AngioSoma's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.

About AngioSoma Management Performance

The success or failure of an entity such as AngioSoma often depends on how effective the management is. AngioSoma management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of AngioSoma management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the AngioSoma management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
GlobeStar Therapeutics Corporation, a clinical stage pharmaceutical company, focuses on developing a patented formulation of drugs for the treatment of multiple sclerosis and other neurodegenerative diseases. The company was incorporated in 2016 and is based in Richland, Washington. Globestar Therapeutics is traded on OTC Exchange in the United States.
Please note, the presentation of AngioSoma's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, AngioSoma's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of AngioSoma's management manipulating its earnings.

AngioSoma Workforce Analysis

Traditionally, organizations such as AngioSoma use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare AngioSoma within its industry.

AngioSoma Manpower Efficiency

Return on AngioSoma Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee248K
Net Loss Per Executive248K

Complementary Tools for AngioSoma Pink Sheet analysis

When running AngioSoma's price analysis, check to measure AngioSoma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AngioSoma is operating at the current time. Most of AngioSoma's value examination focuses on studying past and present price action to predict the probability of AngioSoma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AngioSoma's price. Additionally, you may evaluate how the addition of AngioSoma to your portfolios can decrease your overall portfolio volatility.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
AI Portfolio Prophet
Use AI to generate optimal portfolios and find profitable investment opportunities
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios